Birchtech's second quarter landed with two parallel stories running through the same set of books. The operating business - specialty activated carbon for mercury capture at coal-fired utilities, plus an early-stage water-treatment pivot around PFAS - produced $3.8 million of revenue (+16.5% year over year), $1.0 million of GAAP gross profit, a wider net loss, and operating cash use that ran about two and a half times the year-ago quarter. The other story is the $78.4 million patent judgment Birchtech won in Delaware in late December, currently under appeal, with every utility defendant but one now settled and the IPR proceedings that threatened the patent estate fully concluded. The market closed the day this report was filed at $1.29 - a 52-week low - valuing the equity at roughly $34 million, more than $40 million below the judgment face value. The question the quarter answers is whether the operating burn ($5.0 million of H1 2026 operating cash use) outruns the litigation clock before the appeal resolves, or whether the company has enough cash and enough optionality on the appeal to bridge the gap. Two operating facts set the frame: H1 2026 revenue rose 24% year over year to $8.0 million, the strongest first half since the 2024 G&A reset; and the company emerged from a previously disclosed going-concern qualification in February, when a $16.4 million public offering lifted cash from $2.2 million to $11.8 million.
The biggest load-bearing observation of the quarter is not the $3.0 million net loss, but rather the $1.25 million of "license and settlement fees" Birchtech recorded on the income statement as a result of the May 28, 2026 settlement with the final IPR-participating utility. The settlement cleared the IPR threat, dismissed the last of the consolidated Iowa cases, but also cost Birchtech $500,000 paid up front and a contingent $750,000 payable only if the Delaware judgment survives appeal. Of the $1.25 million recognized, $500,000 is real cash already out the door, and the remaining $750,000 is a contingent charge that exists or vanishes with the appeal. The quarter is therefore the moment the IPR risk was retired - quietly, with a one-time charge that hides inside other income (expense) - and the only remaining large legal question is the appeal itself. The 8/13/2026 quarterly report lands with the operating business on a cleaner footing than it has had in two years, the IPR threat fully closed, and the appellate court clock as the single named catalyst the equity narrative now turns on.